First Ascent Biomedical, an oncology decision support platform, announced on Monday the official opening of a Functional Precision Medicine (FPM) laboratory in Miami, Florida.

The Miami lab is now accepting patient samples through physician referral.

The Clinical Laboratory Improvement Amendments (CLIA)-certified and College of American Pathologists (CAP)-certified laboratory aims to help oncologists move toward personalized cancer treatments faster and more confidently by testing therapies directly against patient-derived live tumor cells for actionable, individualized treatment insights.

Jim Foote, First Ascent Biomedical CEO and co-founder, said: "Our guiding principle is that no two people are the same. No two cancers are the same, and our testing helps oncologists treat accordingly."